Germany · Delayed Price · Currency is EUR Autolus Therapeutics Statistics
Total Valuation
FRA:6A3A has a market cap or net worth of EUR 556.50 million. The enterprise value is 698.90 million.
| Market Cap | 556.50M |
| Enterprise Value | 698.90M |
Important Dates
The last earnings date was Tuesday, August 11, 2026.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +2.10% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 0.57% |
| Owned by Institutions (%) | 18.94% |
| Float | 118.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.42 |
| PB Ratio | 8.50 |
| P/TBV Ratio | 11.29 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.95 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.89, with a Debt / Equity ratio of 4.91.
| Current Ratio | 4.89 |
| Quick Ratio | 4.06 |
| Debt / Equity | 4.91 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.58 |
| Interest Coverage | -5.47 |
Financial Efficiency
Return on equity (ROE) is -133.00% and return on invested capital (ROIC) is -28.12%.
| Return on Equity (ROE) | -133.00% |
| Return on Assets (ROA) | -25.44% |
| Return on Invested Capital (ROIC) | -28.12% |
| Return on Capital Employed (ROCE) | -58.22% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 136,456 |
| Profits Per Employee | -325,658 |
| Employee Count | 754 |
| Asset Turnover | 0.19 |
| Inventory Turnover | 7.14 |
Taxes
In the past 12 months, FRA:6A3A has paid 592,578 in taxes.
| Income Tax | 592,578 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +33.56% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +33.56% |
| 50-Day Moving Average | 1.51 |
| 200-Day Moving Average | 1.35 |
| Relative Strength Index (RSI) | 62.63 |
| Average Volume (20 Days) | 385 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.47 |
Income Statement
In the last 12 months, FRA:6A3A had revenue of EUR 102.75 million and -245.22 million in losses. Loss per share was -0.92.
| Revenue | 102.75M |
| Gross Profit | -76.66M |
| Operating Income | -216.28M |
| Pretax Income | -244.63M |
| Net Income | -245.22M |
| EBITDA | -207.07M |
| EBIT | -216.28M |
| Loss Per Share | -0.92 |
Balance Sheet
The company has 176.49 million in cash and 321.95 million in debt, with a net cash position of -145.46 million.
| Cash & Cash Equivalents | 176.49M |
| Total Debt | 321.95M |
| Net Cash | -145.46M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 65.51M |
| Book Value Per Share | 0.25 |
| Working Capital | 233.97M |
Cash Flow
In the last 12 months, operating cash flow was -197.47 million and capital expenditures -6.24 million, giving a free cash flow of -203.71 million.
| Operating Cash Flow | -197.47M |
| Capital Expenditures | -6.24M |
| Depreciation & Amortization | 9.03M |
| Net Borrowing | n/a |
| Free Cash Flow | -203.71M |
| FCF Per Share | n/a |
Margins
Gross margin is -74.60%, with operating and profit margins of -210.49% and -238.65%.
| Gross Margin | -74.60% |
| Operating Margin | -210.49% |
| Pretax Margin | -238.08% |
| Profit Margin | -238.65% |
| EBITDA Margin | -201.53% |
| EBIT Margin | -210.49% |
| FCF Margin | n/a |
Dividends & Yields
FRA:6A3A does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.10% |
| Shareholder Yield | -2.10% |
| Earnings Yield | -44.06% |
| FCF Yield | -36.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FRA:6A3A has an Altman Z-Score of -4.39 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.39 |
| Piotroski F-Score | 3 |